Brief: Hemogenyx Pharma Says Clinical Hold Lift Plan Accepted By FDA

Hemogenyx Pharmaceuticals

14/09/2023 07:45

Sept 14 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * CLINICAL HOLD LIFT PLAN IS ACCEPTED BY FDA
    * FDA ACCEPTED CO'S PLAN TO ADDRESS FDA'S CONCERNS THAT
RESULTED
IN CLINICAL HOLD OF HEMO-CAR-T IND APPLICATION

Source text for Eikon:  ID:nRSN3723Ma 
Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;;))